Chronic intestinal pseudo-obstruction can occur as a paraneoplastic disorder, and several cases have been reported in association with thymoma or small-cell lung cancer. Autoantibodies against voltage-gated potassium channels (VGKCs) are found in acquiredneuromyotonia (Isaac’s syndrome), and have been reported in one case of slow transit constipation without apparent neurological disease. We describe a patient with VGKC antibodies, acquired neuromyotonia and thymoma, who first presented with a severe slow-transit constipation and in whom the gastrointestinal symptoms responded well to plasmapheresis. We suggest that VGKC antibodies might be helpful in patients with possible paraneoplastic chronic intestinal pseudo-obstruction, and a positive result should stimulate the search for a thymoma or other tumour and raise the possibility of immunotherapy.

Keywords:
Neuromyotonia, Thymoma, Chronic intestinal pseudo-obstruction, Voltage-gated potassium channels
1.
Lang B, Vincent A: Autoantibodies to ion channels at the neuromuscular junction. Autoimmun Rev 2003;2:94–100.
2.
Shillito P, Molenaar PC, Vincent A, et al: Acquired neuromyotonia: Evidence for autoantibodies directed against K+ channels of peripheral nerves. Ann Neurol 1995;38:714–722.
3.
Knowles CH, Lang B, Clover L, Scott SM, Gotti C, Vincent A, Martin JE: A role for autoantibodies in some cases of acquired non-paraneoplastic gut dysmotility. Scand J Gastroenterol 2002;37:166–170.
4.
Smith DS, Williams CS, Ferris CD: Diagnosis and treatment of chronic gastroparesis and chronic intestinal pseudo-obstruction. Gastroenterol Clin North Am 2003;32:619–658.
5.
Camilleri M: Disorders of gastrointestinal motility in neurologic diseases. Mayo Clin Proc 1990;65:825–846.
6.
Chinn JS, Schuffler MD: Paraneoplastic visceral neuropathy as a cause of severe gastrointestinal motor dysfunction. Gastroenterology 1988;95:1279–1286.
7.
Anderson NE, Hutchinson DO, Nicholson GJ, Aitcheson F, Nixon JM: Intestinal pseudo-obstruction, myasthenia gravis, and thymoma. Neurology 1996;47:985–987.
8.
Lennon VA, Sas DF, Busk MF, Scheithauer B, Malagelada JR, Camilleri M, Miller LJ: Enteric neuronal autoantibodies in pseudoobstruction with small-cell lung carcinoma. Gastroenterology 1991;100:137–142.
9.
Sandroni P, Vernino S, Klein CM, Lennon VA, Benrud-Larson L, Sletten D, Low PA: Idiopathic autonomic neuropathy: Comparison of cases seropositive and seronegative for ganglionic acetylcholine receptor antibody. Arch Neurol 2004;61:44–48.
10.
Hart IK, Maddison P, Newsom-Davis J, Vincent A, Mills KR: Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain 2002;125:1887–1895.
11.
Benito-Leon J, Martin E, Vincent A, Fernandez-Lorente J, de Blas G: Neuromyotonia in association with essential thrombocythemia. J Neurol Sci 2000;173:78–79.
12.
Kamm MA: Primary and secondary disorders to gut muscle and nerve. Scand J Gastroenterol 1996;220:91–93.
13.
Wedel T, Spiegler J, Soellner S, Roblick UJ, Schiedeck TH, Bruch HP, Krammer HJ: Enteric nerves and interstitial cells of Cajal are altered in patients with slow-transit constipation and megacolon. Gastroenterology 2002;123:1459–1467.
14.
Tabbaa MA, Leshner RT, Campbell WW: Malignant thymoma with dysautonomia and disordered neuromuscular transmission. Arch Neurol 1986;43:955–957.
15.
Kulling D, Reed CE, Verne GN, Cotton PB, Tarnasky PR: Intestinal pseudo-obstruction as a paraneoplastic manifestation of malignant thymoma. Am J Gastroenterol 1997;92:1564–1566.
16.
Vernino S, Low PA, Fealey RD, Stewart JD, Farrugia G, Lennon VA: Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med 2000;343:847–855.
17.
Madrid A, Gil-Peralta A, Gil-Neciga E, Gonzalez JR, Jarrin S: Morvan’s fibrillary chorea: Remission after plasmapheresis. J Neurol 1996;243:350–353.
18.
Liguori R, Vincent A, Clover L, Avoni P, Plazzi G, Cortelli P, et al: Morvan’s syndrome: Peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain 2001;124:2417–2426.
19.
Vernino S, Adamski J, Kryzer TJ, Fealey RD, Lennon VA: Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes. Neurology 1998;50:1806–1813.
20.
Klein CM, Vernino S, Lennon VA, Sandroni P, Fealey RD, Benrud-Larson L, Sletten D, Low PA: The spectrum of autoimmune autonomic neuropathies. Ann Neurol 2003;53:752–758.
21.
Lennon VA, Ermilov LG, Szurszewski JH, Vernino S: Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease. J Clin Invest 2003;111:907–913.
© 2005 S. Karger AG, Basel
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.